Electrome · Evidence

Wound Healing

Adjunctive PRFE / PSWT studies and preclinical wound-healing mechanism work.

publication

Pulsed Radiofrequency Electromagnetic Field Therapy as an Adjunct Wound Healing Therapy

Narrative review of PRFE therapy as an adjunctive approach across chronic wound, postoperative healing, and cellular tissue-repair literature.

View source
publication

Pulsed Radiofrequency Energy Accelerates Impaired Wound Healing

Controlled preclinical model evaluating wound-closure and contraction dynamics under pulsed radiofrequency energy exposure.

View source
publication

Effect of Pulsed Radio Frequency Energy Treatment on Lower Extremity Wound Healing

Adjunctive PRFE evaluation in patients with lower-extremity wounds; serial wound assessment of healing progression.

View source
Educational summary only. Not medical advice. Individual results vary. Consult a qualified healthcare provider before making treatment decisions. ActiPatch® is FDA-cleared (K192234) for musculoskeletal pain; RecoveryRx® is FDA-cleared (K190251) for adjunctive treatment of postoperative pain. Study outcomes such as edema reduction are evidence findings, not additional cleared indications. Both devices are developed and manufactured by BioElectronics Corporation and marketed by Electrome under an exclusive license.